SCHEMBL1590322

SCHEMBL1590322

Cc1ccccc1CC(=O)Nc1cccc2c(=O)n(CC(C)O)ccc12

nearest known ligand 0.49

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.43
KDM4E B2RXH2 1/20 0.43
P2RX7 Q99572 6/20 0.42
GRM2 Q14416 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
SHMT2 P34897 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1590393 0.91 ALDH1A1 (0.41) ALDH1A1HPGDKDM4EP2RX7GRM2
SCHEMBL1590729 0.89 KMT2A (0.52) ALDH1A1HPGDKDM4EPOLB
SCHEMBL1591178 0.89 PARP14 (0.48) ALDH1A1HPGDKDM4EP2RX7GRM2
SCHEMBL1590436 0.88 GRM2 (0.53) ALDH1A1HPGDKDM4EP2RX7GRM2
SCHEMBL1590422 0.88 ALDH1A1 (0.52) ALDH1A1HPGDKDM4EP2RX7MAPT
SCHEMBL1591059 0.87 KDM4E (0.55) ALDH1A1HPGDKDM4EGRM2MAPT
SCHEMBL1590987 0.86 P2RX7 (0.49) ALDH1A1HPGDKDM4EP2RX7GRM2
SCHEMBL1591484 0.85 P2RX7 (0.43) ALDH1A1HPGDKDM4EP2RX7POLB
SCHEMBL1590410 0.85 TP53 (0.56) ALDH1A1HPGDKDM4EGRM2POLB
SCHEMBL1590888 0.84 P2RX7 (0.48) ALDH1A1HPGDKDM4EP2RX7GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. 2011-04-21 US claimed
US-7816371-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2010-10-19 US claimed
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof SECOND GENOME, INC. 2007-09-27 US claimed
EP-1933622-B1 BICYCLOHETEROARYL COMPOUNDS AS P2X7 MODULATORS AND USES THEREOF SECOND GENOME INC (US) 2016-03-09 EP disclosed
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. 2011-04-21 US disclosed
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. 2011-04-21 US disclosed
US-7816371-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2010-10-19 US disclosed
US-7816371-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2010-10-19 US disclosed
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof SECOND GENOME, INC. 2007-09-27 US disclosed
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof SECOND GENOME, INC. 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof P2RX7, P2RX3, P2RX2 ALDH1A1 3640/4885HPGD 368/4885KDM4E 4128/4885
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof P2RX7, P2RX3, P2RX2 ALDH1A1 3640/4885HPGD 368/4885KDM4E 4128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.